National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 36426-36427 [2010-15485]
Download as PDF
36426
Federal Register / Vol. 75, No. 122 / Friday, June 25, 2010 / Notices
been approved under OMB control no.
0910–0073; the collections of
information in 21 CFR part 610 have
been approved under OMB control nos.
0910–0116 and 0910–0338; and the
collections of information in 21 CFR
809.10 have been approved under OMB
control no. 0910–0485.
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) either electronic or written
comments regarding this document. It is
only necessary to send one set of
comments. It is no longer necessary to
send two copies of mailed comments.
Identify comments with the docket
number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: June 21, 2010.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2010–15417 Filed 6–24–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Legislative Changes to Nursing
Student Loan Program Authorized
Under Title VIII of the Public Health
Service Act
Health Resources and Services
Administration, HHS.
ACTION: Notice.
mstockstill on DSKH9S0YB1PROD with NOTICES
AGENCY:
SUMMARY: On March 23, 2010, President
Obama signed into law the Patient
Protection and Affordable Care Act
(ACA), Public Law (Pub. L.) 111–148.
Section 5202 of the ACA changes the
Nursing Student Loan (NSL) program
by: (1) Increasing the limits of loan
funds to students; (2) revising the date
of enrollment to be considered eligible
to receive NSL funds; and (3) revising
the date of loans eligible for partial loan
cancellation.
SUPPLEMENTARY INFORMATION: The
Nursing Student Loan (NSL) program
was authorized by the Nurse Training
Act of 1964 (Pub. L. 88–581) to alleviate
the shortage of nursing personnel and to
assure that no qualified student was
denied the pursuit of a nursing career
due to lack of financial resources. The
NSL program provides long-term, lowinterest loans to full-time and half-time
students to help meet the cost of
education. Students are eligible to apply
VerDate Mar<15>2010
16:23 Jun 24, 2010
Jkt 220001
for the NSL program if pursuing a
course of study leading to a diploma in
nursing, an associate or bachelor’s
degree in nursing or an equivalent
degree, or a graduate degree in nursing.
Below are details on how the ACA
changes Sections 836(a), 836(b)(1), and
836(b)(3) of the Public Health Service
Act, respectively, regarding the
administration of the NSL program.
Loan Funding Limits
The ACA increases the maximum
amount of NSL funding a student can
receive. Previously, the total amount of
NSL funds for any academic year could
not exceed $2,500 in the case of any
student except that, for the final 2
academic years of the program involved,
such total could not exceed $4,000.
With the legislative change, however,
the new total amount of the loans for
any academic year from NSL funds may
not exceed $3,300 in the case of any
student except that, for the final two
academic years of the program involved,
such total may not exceed $5,200.
Prior to the ACA, the aggregate of the
NSL loans for all years from such funds
was a maximum of $13,000 in the case
of any student. Now, the aggregate of the
loans for all years from such funds may
not exceed $17,000 in the case of any
student during fiscal years 2010 and
2011. After fiscal year 2011, the
amounts shall be adjusted to provide for
a cost-of-attendance increase for the
yearly loan rate and the aggregate of the
loans. (Section 5202(a) of the ACA.)
Date of Enrollment
The ACA changes the date a student
of financial need must be enrolled in a
nursing program in order to be eligible
to receive NSL funds. Previously an
NSL loan could be made to a student of
financial need who was enrolled after
June 30, 1986. Now, an NSL loan can be
made to a student of financial need who
was enrolled after June 30, 2000.
(Section 5202(b)(1) of the ACA.)
To be eligible, students are still also
required to: (1) Pursue a full-time or
half-time course of study at the school
leading to a baccalaureate or associate
degree in nursing or an equivalent
degree, or a diploma in nursing, or a
graduate degree in nursing and (2) be
capable, in the opinion of the school, of
maintaining good standing in such
course of study.
Partial Loan Cancellation Date
Prior to the ACA, students who
received NSL loans before September
29, 1979, could receive partial
cancellation of their loans. Now,
however, partial loan cancellation
applies to loans received by students
PO 00000
Frm 00081
Fmt 4703
Sfmt 4703
before September 29, 1995. (Section
5202(b)(2) of the ACA.)
A student who received such an NSL
before September 29, 1995, can have an
amount up to 85 percent of that nursing
student loan (plus interest thereon)
cancelled for full-time employment as a
professional nurse in any public or nonprofit private agency, institution, or
organization, at the rate of 15 percent of
the amount of such loan (plus interest)
unpaid on the first day of such service
for each of the first, second, and third
complete year of such service, and 20
percent of such amount (plus interest)
for each complete fourth and fifth year
of such service. Employment as a
professional nurse may include teaching
in any of the fields of nurse training and
serving as an administrator, supervisor,
or consultant in any of the fields of
nursing. Nursing experience prior to
March 23, 2010 will not be considered
in determining loan cancellation.
Dated: June 21, 2010.
Mary K. Wakefield,
Administrator.
[FR Doc. 2010–15421 Filed 6–24–10; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel, Host-Pathogen Interactions.
Date: August 2, 2010.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817.
Contact Person: Lynn Rust, PhD, Scientific
Review Officer, Scientific Review Program,
Division of Extramural Activities, NIAID/
NIH/DHHS, Room 3120, 6700B Rockledge
E:\FR\FM\25JNN1.SGM
25JNN1
Federal Register / Vol. 75, No. 122 / Friday, June 25, 2010 / Notices
Drive, MSC 7616. Bethesda, MD 20892. 301–
402–3938. lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: June 21, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–15485 Filed 6–24–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meetings
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Resource Related Research Project in
National Biological Sample Data Repository.
Date: July 7, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178,
Bethesda, MD 20892–7924. 301–435–0725.
johnsonw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Resource Related Research Project in Lung
Disease BioRepository.
Date: July 15, 2010.
Time: 11 a.m. to 2 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178,
VerDate Mar<15>2010
16:23 Jun 24, 2010
Jkt 220001
Bethesda, MD 20892–7924. 301–435–0725,
johnsonw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Coordinating Center for Systems Biology
Approach to the Mechanisms of Tuberculosis
(TB) Latency and Reactivation.
Date: July 16, 2010.
Time: 8 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Doubletree Hotel Bethesda,
(Formerly Holiday Inn Select), 8120
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Holly K Krull, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7188,
Bethesda, MD 20892–7924. 301–435–0280.
krullh@nhlbi,nih.gov
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Career Enhancement Award for Stem Cell
Research.
Date: July 27, 2010.
Time: 10:30 a.m. to 2:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
(Telephone Conference Call.)
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178,
Bethesda, MD 20892–7924. 301–435–0725.
johnsonw@nhlbi.nih.gov.
Name of Committee: National Heart, Lung,
and Blood Institute Special Emphasis Panel,
Program Project in Cardiovascular Disease.
Date: July 29, 2010.
Time: 10 a.m. to 3 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard by Marriott, 5520
Wisconsin Avenue, Chevy Chase, MD 20815.
Contact Person: William J Johnson, PhD,
Scientific Review Officer, Review Branch/
DERA, National Heart, Lung, and Blood
Institute, 6701 Rockledge Drive, Room 7178,
Bethesda, MD 20892–7924. 301–435–0725.
johnsonwj@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Dated: June 18, 2010.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–15487 Filed 6–24–10; 8:45 am]
BILLING CODE 4140–01–P
PO 00000
Frm 00082
Fmt 4703
Sfmt 4703
36427
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
National Advisory Council on the
National Health Service Corps; Notice
of Meeting
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Public Law 92–463), notice is hereby
given of the following meeting:
Name: National Advisory Council on
the National Health Service Corps
(NHSC).
Date and Time: August 4, 2010, 9
a.m.–4 p.m.
Place: Renaissance Washington, DC
Downtown Hotel, 999 Ninth Street,
NW., Washington, DC 20001, Phone:
202–898–9000.
Status: The meeting will be open to
the public.
Agenda: The Council will be
convening in Washington, DC to hear
updates on the NHSC program and to
review and discuss the NHSC’s vision,
mission and values statements.
FOR FURTHER INFORMATION CONTACT:
Njeri Jones, Bureau of Clinician
Recruitment and Service, Health
Resources and Services Administration,
Parklawn Building, Room 8A–46, 5600
Fishers Lane, Rockville, MD 20857; email: NJones@hrsa.gov; telephone: 301–
443–2541.
Dated: June 21, 2010.
Sahira Rafiullah,
Director, Division of Policy Information and
Coordination.
[FR Doc. 2010–15420 Filed 6–24–10; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0001]
Joint Meeting of the Arthritis Advisory
Committee and the Drug Safety and
Risk Management Advisory
Committee; Notice of Meeting
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committees: Arthritis
Advisory Committee and the Drug
Safety and Risk Management Advisory
Committee.
E:\FR\FM\25JNN1.SGM
25JNN1
Agencies
[Federal Register Volume 75, Number 122 (Friday, June 25, 2010)]
[Notices]
[Pages 36426-36427]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-15485]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel, Host-Pathogen Interactions.
Date: August 2, 2010.
Time: 9 a.m. to 2 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6700B Rockledge Drive,
Bethesda, MD 20817.
Contact Person: Lynn Rust, PhD, Scientific Review Officer,
Scientific Review Program, Division of Extramural Activities, NIAID/
NIH/DHHS, Room 3120, 6700B Rockledge
[[Page 36427]]
Drive, MSC 7616. Bethesda, MD 20892. 301-402-3938. lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: June 21, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-15485 Filed 6-24-10; 8:45 am]
BILLING CODE 4140-01-P